Skip to main content
OpenTrials

Clinical trial condition

Cholestasis, Intrahepatic

Explore clinical trials studying Cholestasis, Intrahepatic. Study availability and eligibility vary by location and protocol.

169 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Cholestasis, Intrahepatic trial results

Active, Not Recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Patients With Primary Biliary Cholangitis

NCT07573514

Conditions
Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +20 more
Locations
  • Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
View Trial Details
Active, Not Recruiting

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capitai Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 16 locations
View Trial Details
Active, Not Recruiting

Liver Cirrhosis Network Cohort Study

NCT05740358

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Autoimmune Diseases, +34 more
Locations
  • University of California San Diego NAFLD Research Center La Jolla, California, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • LAC + USC Medical Center Los Angeles, California, United States
  • UCSF/Zuckerberg San Francisco General Hospital and Trauma Center San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT06174402

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The second hospital of Lanzhou University Lanzhou, Gansu, China
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details

Related conditions